MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia
- PMID: 9160687
MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia
Abstract
To study prognostic factors in infant acute myeloid leukemia (AML), we analyzed 44 children treated on Childrens Cancer Group protocols for MLL gene rearrangement by Southern blot, cytogenetic 11q23 abnormalities, and reactivity with monoclonal antibody 7.1. This antibody detects the human homologue of the rat NG2 chondroitin sulfate proteoglycan molecule, which has previously been reported to be expressed on human melanoma. NG2 has been found to be expressed on human leukemic blasts but not on other hematopoietic cells. In childhood AML, NG2 cell surface expression correlated with poor outcome and with some but not all 11q23 rearrangements. In childhood acute lymphoblastic leukemia, NG2 expression correlated with poor outcome and with balanced 11q23 translocations. In this study, 29 of 44 (66%) of infants with AML showed MLL rearrangement and, as expected, this group had a high incidence of French-American-British M4/M5 morphology (22/29). Of the cases tested, 35.1% (13/37) were NG2 positive. All (13/13) NG2-positive cases were rearranged at MLL, whereas only 46% (11/24) of NG2-negative cases had MLL rearrangement. NG2 expression did not correlate with poor outcome (P = .31); there was a trend towards a worse outcome with MLL rearrangement (P = .13). Thus monoclonal antibody 7.1 does not detect all cases of MLL rearrangement in infant AML.
Similar articles
-
The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.Blood. 1996 Feb 1;87(3):1123-33. Blood. 1996. PMID: 8562938 Clinical Trial.
-
Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.Blood. 1996 Feb 1;87(3):1134-9. Blood. 1996. PMID: 8562939
-
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.Leukemia. 2000 Jul;14(7):1232-8. doi: 10.1038/sj.leu.2401840. Leukemia. 2000. PMID: 10914547
-
Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 11q23/MLL rearrangements.Genes Chromosomes Cancer. 2000 Feb;27(2):136-42. Genes Chromosomes Cancer. 2000. PMID: 10612801 Review.
-
Molecular analysis of infant acute leukemia.Leuk Lymphoma. 1997 Apr;25(3-4):191-9. doi: 10.3109/10428199709114159. Leuk Lymphoma. 1997. PMID: 9168430 Review.
Cited by
-
Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia.Cancers (Basel). 2021 Sep 26;13(19):4817. doi: 10.3390/cancers13194817. Cancers (Basel). 2021. PMID: 34638301 Free PMC article.
-
Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blasts.Oncol Res. 2015;22(2):117-21. doi: 10.3727/096504014X14174484758503. Oncol Res. 2015. PMID: 25706398 Free PMC article.
-
Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias.Front Pharmacol. 2022 Jun 6;13:749472. doi: 10.3389/fphar.2022.749472. eCollection 2022. Front Pharmacol. 2022. PMID: 35734412 Free PMC article.
-
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance.Cancers (Basel). 2019 Aug 16;11(8):1198. doi: 10.3390/cancers11081198. Cancers (Basel). 2019. PMID: 31426437 Free PMC article.
-
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms.J Cell Biol. 2004 Jun 21;165(6):881-91. doi: 10.1083/jcb.200403174. J Cell Biol. 2004. PMID: 15210734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources